Posted on 5th April 2024

Canavan gene therapy

Children with Canavan Disease receiving gene therapy in trial

Hear from one of the first families with a child to receive gene therapy for Canavan Disease as part of the CANaspire clinical trial by Aspa Therapeutics, a BridgeBio company.

To read: https://www.bizjournals.com/boston/news/2024/04/01/groundbreaking-gene-therapy-offers-glimmer-of-hope.html